Sacu V 50 Tablet 14

Glenmark Pharmaceuticals Ltd.

Strip of 14 Units

MRP ₹291

₹238.62

₹20.79/Units

18% off
*MRP inclusive of all taxes
Get it By
Change
Choose your location

Use your current location

Login to view saved addresses

100% genuine medicines

Safe & secure payments

15 days Easy returns

Prescription required for this medicine

Store Below 30o C

Strength:

About Sacu V 50 Tablet 14

Sacu-V 50 Tablet is primarily used to manage symptomatic chronic heart failure with reduced ejection fraction. This combination medication falls under the category of neprilysin inhibitors and angiotensin II receptor blockers (ARBs).

This tablet manages heart failure and helps reduce the risk of cardiovascular death and hospitalisation. It works in conjunction with other heart failure therapies to improve survival and alleviate clinical symptoms in patients.

Before starting this medication, it's crucial you consult your doctor about your dosage and frequency. Be sure to inform them about any preexisting conditions or ongoing medications. If you notice any side effects while taking this medicine, notify your doctor right away. Continue taking the medicine for the duration prescribed by your doctor for optimal results.

Certified Content

Written by

Dr Vatsalya D Ghanekar
Dr Vatsalya D Ghanekar
Medical Content Writer | 5 years

MD Ayurveda

Reviewed by

Dr. Meenakshi Maruwada
Dr. Meenakshi Maruwada
Medical Content Writer & Strategist | 8 years

BDS, PGCAD, GMHE (IIM-B)

Check out Editorial Policy

Manufacturer details

Glenmark House, HDO-Corporate Building, Wing-A, B.D. Sawant Marg, Chakala Off. Western Express Highway, Andheri (East), Mumbai​, Maharashtra, 400099 India

Country of origin: INDIA

References

  • U.S. Food and Drug Administration. (2015). FDA Drug Safety Communication: FDA warns about new impulse control problems associated with mental health drug aripiprazole (Abilify, Abilify Maintena, Aristada). Retrieved from https://www.fda.gov/media/134841/download on 1 April 2024.

  • Nicolas D, Kerndt CC, Patel P, et al. (2022, May 26). Sacubitril-valsartan - StatPearls - NCBI bookshelf. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK507904/

Was this product description useful?
36 people find this information helpful

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.

Subscribe

Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.

Download Truemeds

Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.

playstoreIcon

Contact Us

Our customer representative team is available 7 days a week from 9 am - 9 pm.


v3.4.16

copyright2024 - Truemeds | All rights reserved

Our Payment Partners

paymentPartnerpaymentPartnerpaymentPartnerpaymentPartnerpaymentPartner
paymentPartnerpaymentPartnerpaymentPartnerpaymentPartner